American Journal of Cardiology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
SYNERGY—Everolimus-Eluting Stent With a Bioabsorbable Polymer in ST-Elevation Myocardial Infarction: CLEAR SYNERGY OASIS-9 Registry
2024
-
AS-063 Correlation of Fractional Flow Reserve to the Ratio of Instantaneous Distal/Proximal Pressures at The Point of Diastolic Inflection
2011
-
Arterial Closure vs Direct Compression for Hemostasis After Percutaneous Coronary Interventions - The ACDC Trial
2009
-
Contrast nephropathy in patients with chronic kidney disease undergoing either diagnostic or interventional procedures
2007
-
Efficacy and safety at 3 and 5 years in the Canadian multicenter, randomized, double-blind trial of the sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions (C-SIRIUS)
2007
-
Efficacy and safety at 3 years of the sirolimus-eluting stent for the treatment of patients with long lesions in small vessels from the Canadian multicenter, randomized, double-blind trial C-SIRIUS
2005
-
Treating patients with non-ST-elevation acute coronary syndromes with aggressive antiplatelet agents in the GRACE registry: No observed improvement in hospital outcomes
2003
-
Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target
2003
-
American Journal of Cardiology: Introduction
2002
-
Stenting and glycoprotein IIb/IIIa inhibition in angioplasty for acute myocardial infarction (AMI) in the Global Registry of Acute Coronary Events (GRACE).
2001
-
The thrombin-specific anticoagulant, bivalirudin, completely inhibits thrombin-mediated platelet aggregation.
2001
-
Bivalirudin during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia: Interim results of the ATBAT trial.
2000
-
Treatment of no-reflow with the intracoronary administration of the nitric oxide donor nitroprusside: Initial human clinical experience.
1999
-
Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin
1998
-
Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial
1998
-
Editorial
1997
-
Diagnosis of venous thrombosis and pulmonary embolism
1990
-
Pain relief in acute myocardial infarction by intravenous atenolol
1981
-
Reduction in infarct size and morbidity by early intravenous betablockade
1981
-
PLATELET SURVIVAL-TIME AND BETA-THROMBOGLOBULIN IN CARDIAC-VALVE REPLACEMENT
1981
-
Assessment of Coronary Stenoses for Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis of Randomized Trials.
223:29-39.
2024
-
Risk Scores for Prediction of Postoperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-Analysis.
209:232-240.
2023
-
Validation of the OPEN-CLEAN Chronic Total Occlusion Percutaneous Coronary Intervention Perforation Score in a Multicenter Registry.
188:30-35.
2023
-
Relation of Extracardiac Vascular Disease and Outcomes in Patients With Diabetes (1.1 Million) Hospitalized for Acute Myocardial Infarction.
175:8-18.
2022
-
Meta-Analysis of Nonalcoholic Fatty Liver Disease and Incident Heart Failure.
171:180-181.
2022
-
Does a Heart Team Improve Clinical Outcomes?.
169:120-126.
2022
-
Reply to Standard Versus Higher Intensity Anticoagulation for Patients With Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism.
168:172-173.
2022
-
Meta-Analysis of Surgical Left Atrial Appendage Occlusion During Cardiac Surgery.
166:145-146.
2022
-
Predictors, Treatments, and Outcomes of Do-Not-Resuscitate Status in Acute Myocardial Infarction Patients (from a Nationwide Inpatient Cohort Study).
159:8-18.
2021
-
Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial).
149:27-35.
2021
-
A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation.
131:40-48.
2020
-
Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease.
130:1-6.
2020
-
Socioeconomic Status and Differences in the Management and Outcomes of 6.6 Million US Patients With Acute Myocardial Infarction.
129:10-18.
2020
-
Impact of Routine 24 Hour Coronary Care Unit Stay in Stable Patients After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
125:1770-1773.
2020
-
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry.
125:383-391.
2020
-
Relation of Increasing QRS Duration Over Time and Cardiovascular Events in Outpatients With Heart Failure.
124:1907-1911.
2019
-
Relation of Frailty to Outcomes in Patients With Acute Coronary Syndromes.
124:1002-1011.
2019
-
Early Unplanned Readmissions After Admission to Hospital With Heart Failure.
124:736-745.
2019
-
Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared With Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation.
123:1385-1385.
2019
-
Comparison of Frequency of Ischemic Stroke in Patients With Versus Without Coronary Heart Disease and Without Atrial Fibrillation.
123:153-158.
2019
-
Lifetime Pattern of Atrial Fibrillation and the Risks of Stroke and Death in a Population-based Cohort of Men (from The Manitoba Follow-Up Study).
122:1688-1693.
2018
-
Relationship Between Psychosocial Stressors and Atrial Fibrillation in Women >45 Years of Age.
122:1684-1687.
2018
-
Varying Effects of Body Mass Index and Mortality in Different Risk Groups.
122:1155-1160.
2018
-
Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey).
122:578-583.
2018
-
Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy.
121:975-980.
2018
-
Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A]).
121:584-589.
2018
-
Impact of Left Atrial Appendage Exclusion on Cardiovascular Outcomes in Patients with Atrial Fibrillation Undergoing Coronary Artery Bypass Grafting (from the National Inpatient Sample Database).
121:277-277.
2018
-
Effect of Body Mass Index on Clinical Events After Acute Coronary Syndromes.
120:1453-1459.
2017
-
Comparison of the Frequency of Acute Kidney Injury in Patients With Renal Transplant Who Underwent Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery.
120:1104-1109.
2017
-
Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation.
120:582-587.
2017
-
Comparison of Outcomes of Balloon-Expandable Versus Self-Expandable Transcatheter Heart Valves for Severe Aortic Stenosis.
119:1094-1099.
2017
-
Heart Rate Variability and Sleep-Related Breathing Disorders in the General Population.
118:912-917.
2016
-
Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation.
117:1107-1111.
2016
-
Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention.
117:1256-1266.
2016
-
Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease (A Post Hoc Analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial).
116:1509-1515.
2015
-
Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial).
116:1204-1209.
2015
-
Validation of the Appropriate Use Criteria for Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease (from the COURAGE Trial).
116:167-173.
2015
-
Efficacy and Safety of a Routine Early Invasive Strategy in Relation to Time from Symptom Onset to Fibrinolysis (a Subgroup Analysis of TRANSFER-AMI).
115:1005-1012.
2015
-
Relation of Atrial Fibrillation and Right-Sided Cardiac Thrombus to Outcomes in Patients With Acute Pulmonary Embolism.
115:825-830.
2015
-
Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit).
115:641-646.
2015
-
Comparison of the Efficacy of Pharmacoinvasive Management for ST-Segment Elevation Myocardial Infarction in Smokers Versus Non-Smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction).
114:955-961.
2014
-
Effect of Cardiac Resynchronization Therapy on the Sequence of Mechanical Activation Assessed by Two-Dimensional Radial Strain Imaging.
113:982-987.
2014
-
Prognostic Usefulness of Left Ventricular Hypertrophy by Electrocardiography in Patients With Atrial Fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study).
113:669-675.
2014
-
Health Status and Quality of Life in Patients With Stable Coronary Artery Disease and Chronic Kidney Disease Treated With Optimal Medical Therapy or Percutaneous Coronary Intervention (Post Hoc Findings from the COURAGE Trial).
112:1703-1708.
2013
-
Hospitalization for Hemorrhage Among Warfarin Recipients Prescribed Amiodarone.
112:420-423.
2013
-
Management and Outcomes of Non-ST Elevation Acute Coronary Syndromes in Relation to Previous Use of Antianginal Therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).
112:51-56.
2013
-
Treatment Assignment of High-Risk Symptomatic Severe Aortic Stenosis Patients Referred for Transcatheter AorticValve Implantation.
112:100-103.
2013
-
Factors Associated With the Epidemic of Hospitalizations Due to Atrial Fibrillation.
110:1496-1499.
2012
-
Meta-Analysis Comparing Bivalirudin Versus Heparin Monotherapy on Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention.
110:599-606.
2012
-
Erratum for Harkness K, et al. “Screening for Cognitive Deficits Using the Montreal Cognitive Assessment Tool in Outpatients ≥65 Years of Age With Heart Failure” Am J Cardiol 2011;107:1203–1207.
109:1537-1537.
2012
-
Temporal Patterns of Lipid Testing and Statin Therapy in Acute Coronary Syndrome Patients (from the Canadian GRACE Experience).
109:1418-1424.
2012
-
Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial).
109:954-959.
2012
-
Relation of Renal Function to Risk for Incident Atrial Fibrillation in Women.
109:538-542.
2012
-
Thirty-Year (1975 to 2005) Trends in the Incidence Rates, Clinical Features, Treatment Practices, and Short-Term Outcomes of Patients <55 Years of Age Hospitalized With an Initial Acute Myocardial Infarction.
108:477-482.
2011
-
Effect of gender on treatment and outcomes in severe aortic stenosis..
107:1681-1686.
2011
-
Screening for Cognitive Deficits Using the Montreal Cognitive Assessment Tool in Outpatients ≥65 Years of Age With Heart Failure.
107:1203-1207.
2011
-
Therapeutic Benefit of Preventive Telehealth Counseling in the Community Outreach Heart Health and Risk Reduction Trial.
107:690-696.
2011
-
30-Year Trends in Heart Failure in Patients Hospitalized With Acute Myocardial Infarction.
107:353-359.
2011
-
Relation Between Hemoglobin Level and Recurrent Myocardial Ischemia in Acute Coronary Syndromes Detected by Continuous Electrocardiographic Monitoring.
106:1417-1422.
2010
-
Relation Between Obesity and the Attainment of Optimal Blood Pressure and Lipid Targets in High Vascular Risk Outpatients.
106:1270-1276.
2010
-
Pregnancy Outcomes in Women With Transposition of the Great Arteries and Arterial Switch Operation.
106:417-420.
2010
-
Usefulness of Computed Tomographic Coronary Angiography in Patients With Acute Chest Pain With and Without High-Risk Features.
106:463-469.
2010
-
A National Survey of Canadian Practice Patterns of Warfarin After Anterior Wall Myocardial Infarction in the Current Era of Dual Antiplatelet Therapy.
105:1844-1844.
2010
-
Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]).
104:1484-1489.
2009
-
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease and Chronic Kidney Disease.
104:1647-1653.
2009
-
Predictors of Increased Radiation Dose During Percutaneous Coronary Intervention.
104:1241-1244.
2009
-
Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial.
104:1055-1062.
2009
-
Role of Renin-Angiotensin System Blockade in Patients With Diabetes Mellitus.
104:835-839.
2009
-
Epidemiology of Decompensated Heart Failure in a Single Community in the Northeastern United States.
104:377-382.
2009
-
Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial).
104:1-4.
2009
-
Trends in Atrial Fibrillation Complicating Acute Myocardial Infarction.
104:169-174.
2009
-
Comparison of New Measures of Vascular Function to Flow Mediated Dilatation as a Measure of Cardiovascular Risk Factors.
103:1610-1615.
2009
-
Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]).
103:598-603.
2009
-
Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE]).
103:175-180.
2009
-
Thirty-Year Trends (1975–2005) in the Magnitude, Patient Characteristics, and Hospital Outcomes of Patients With Acute Myocardial Infarction Complicated by Ventricular Fibrillation.
102:1595-1601.
2008
-
Trends in Prehospital Delay in Patients With Acute Myocardial Infarction (from the Worcester Heart Attack Study).
102:1589-1594.
2008
-
Discordance Between Physicians' Estimation of Patient Cardiovascular Risk and Use of Evidence-Based Medical Therapy.
102:1142-1145.
2008
-
Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry).
102:883-889.
2008
-
Reproducibility of Peak Oxygen Uptake and Other Cardiopulmonary Exercise Testing Parameters in Patients With Heart Failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing).
102:712-717.
2008
-
Usefulness of N-Terminal Pro–Brain Natriuretic Peptide and Brain Natriuretic Peptide to Predict Cardiovascular Outcomes in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
102:733-737.
2008
-
First, Remove the Offending Agent.
102:370-371.
2008
-
Relation of Troponin Elevation to Outcome in Patients With Infective Endocarditis.
101:1479-1481.
2008
-
Usefulness of Improvement in Walking Distance Versus Peak Oxygen Uptake in Predicting Prognosis After Myocardial Infarction and/or Coronary Artery Bypass Grafting in Men.
101:1423-1427.
2008
-
The Corrected Values for Duration and Frequency of Angina at Baseline in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial.
100:1604-1604.
2007
-
Comparison of Utilization of Statin Therapy at Hospital Discharge and Six-Month Outcomes in Patients With an Acute Coronary Syndrome and Serum Low-Density Lipoprotein ≥100 mg/dl Versus <100 mg/dl.
100:913-918.
2007
-
The Editor's Roundtable: Arterial Thrombosis and Acute Coronary Syndromes.
100:974-980.
2007
-
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods.
99:S21-S33.
2007
-
Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging for Assessing Right Ventricular Function in Adults With Repaired Tetralogy of Fallot.
99:1593-1597.
2007
-
Glycemia Treatment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.
99:S34-S43.
2007
-
Health-Related Quality of Life and Cost-Effectiveness Components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Rationale and Design.
99:S90-S102.
2007
-
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.
99:S4-S20.
2007
-
Acute Cardiac Functional and Morphological Changes After Anthracycline Infusions in Children.
99:974-977.
2007
-
Analytic Approaches to Establish the Diagnostic Accuracy of Coronary Computed Tomography Angiography as a Tool for Clinical Decision Making.
99:1122-1127.
2007
-
Impact of Radial Artery Cannulation for Coronary Angiography and Angioplasty on Radial Artery Function.
99:457-459.
2007
-
Comparison of Effectiveness of Enoxaparin Versus Unfractionated Heparin to Reduce Silent and Clinically Apparent Acute Myocardial Infarction in Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndrome.
99:186-188.
2007
-
The Evolving Pattern of Symptomatic Coronary Artery Disease in the United States and Canada: Baseline Characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial.
99:208-212.
2007
-
Usefulness of Coronary Computed Tomographic Angiography to Assess Suitability for Revascularization in Patients With Significant Coronary Artery Disease and Angina Pectoris.
98:1198-1201.
2006
-
Impact of Ramipril on the Circadian Periodicity of Acute Myocardial Infarction.
98:758-760.
2006
-
Primary and Rescue Percutaneous Coronary Intervention With Paclitaxel-Eluting Stent Implantation in ST-Elevation Myocardial Infarction.
97:1308-1310.
2006
-
Usefulness of B-Type Natriuretic Peptide and C-Reactive Protein in Predicting the Presence or Absence of Left Ventricular Hypertrophy in Patients With Systemic Hypertension.
97:249-252.
2006
-
Effect of Vasopressin on Hemodynamics in Patients With Refractory Cardiogenic Shock Complicating Acute Myocardial Infarction.
96:1617-1620.
2005
-
Intensity of Lipid Lowering With Statins and Brachial Artery Vascular Endothelium Reactivity After Acute Coronary Syndromes (from the BRAVER Trial).
96:1207-1213.
2005
-
Treating Patients With Acute Coronary Syndromes With Aggressive Antiplatelet Therapy (from the Global Registry of Acute Coronary Events).
96:917-921.
2005
-
Use of Combination Evidence-Based Medical Therapy Prior to Acute Myocardial Infarction (from the National Registry of Myocardial Infarction-4).
96:922-926.
2005
-
Effect of Statin Use Within the First 24 Hours of Admission for Acute Myocardial Infarction on Early Morbidity and Mortality††A complete list of participating hospitals is available from ClinTrials Research, 1100 Weston Parkway, Cary, North Carolina 27513..
96:611-616.
2005
-
Usefulness of Temporal Changes in Neurohormones as Markers of Ventricular Remodeling and Prognosis in Patients With Left Ventricular Systolic Dysfunction and Heart Failure Receiving Either Candesartan or Enalapril or Both.
96:698-704.
2005
-
Regression Analysis of Percutaneous Coronary Intervention Treatment-Related Time Delay.
96:322-322.
2005
-
Trends in Mortality Attributed to Heart Failure in Worcester, Massachusetts, 1992 to 2001.
95:1324-1328.
2005
-
Occurrence of acute myocardial infarction in Worcester, Massachusetts, before, during, and after the terrorists attacks in New York City and Washington, DC, on 11 September 2001.
95:258-260.
2005
-
Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease.
95:249-253.
2005
-
A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study).
94:1373-1378.
2004
-
Angiotensin-converting enzyme inhibitor meta-analysis provides misleading conclusion.
94:149-149.
2004
-
Efficacy of substituting innovator propafenone for its generic formulation in patients with atrial fibrillation.
93:1558-1560.
2004
-
Evidence of adverse ventricular interdependence in patients with atrial septal defects.
93:1374-1377.
2004
-
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
93:1092-1096.
2004
-
Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions.
93:750-753.
2004
-
Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction.
93:234-237.
2004
-
Trends (1986 to 1999) in the incidence and outcomes of in-hospital stroke complicating acute myocardial infarction (The Worcester Heart Attack Study).
92:383-388.
2003
-
Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target..
91:9G-14G.
2003
-
Long-term cardiorespiratory results of exercise training following cardiac transplantation.
91:190-194.
2003
-
Role of infarct size in explaining the higher mortality in older patients with acute myocardial infarction.
90:1370-1374.
2002
-
Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]).
90:1056-1061.
2002
-
Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan.
90:969-973.
2002
-
Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure.
90:496-500.
2002
-
Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non–Q-wave myocardial infarction undergoing percutaneous coronary intervention.
89:1293-1297.
2002
-
A symposium: New frontiers in cardiovascular clinical trials: The ontarget study in high-risk patients - Introduction.
89:1A-2A.
2002
-
Angiotensin II and trials of cardiovascular outcomes - Discussion.
89:16A-17A.
2002
-
From the HOPE to the ONTARGET and the TRANSCEND studies: Challenges in improving prognosis - Discussion.
89:25A-26A.
2002
-
From the hope to the ontarget and the transcend studies: challenges in improving prognosis.
89:18-25.
2002
-
Is exercise testing useful in identifying congenital long QT syndrome?.
89:233-236.
2002
-
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data.
88:1-20.
2001
-
Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2]).
88:107-111.
2001
-
Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement.
88:40-44.
2001
-
A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction.
87:1008-1010.
2001
-
Aerobic capacity in adults with various congenital heart diseases.
87:310-314.
2001
-
Effectiveness and safety of abciximab after failed thrombolytic therapy.
87:439-442.
2001
-
Right and left ventricular systolic function late after repair of tetralogy of Fallot.
86:1352-1357.
2000
-
Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in medical patients with enoxaparin (MEDENOX) trial.
86:48-52.
2000
-
Effect of abciximab on late adverse events in patients with diabetes mellitus undergoing stent implantation.
86:1063-1068.
2000
-
Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction.
86:553-556.
2000
-
Effects of 16 weeks of resistance training on left ventricular morphology and systolic function in healthy men >60 years of age.
85:1002-1006.
2000
-
Usefulness of the QTc interval in predicting myocardial ischemia in patients undergoing exercise stress testing.
85:764-766.
2000
-
Exaggerated initial response to warfarin following heart valve replacement.
84:905-908.
1999
-
Anticoagulants in acute coronary syndromes.
84:2-6.
1999
-
Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes–2 (OASIS–2) trial.
84:20-25.
1999
-
The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina.
84:7-12.
1999
-
The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation.
84:13-19.
1999
-
Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin.
83:1006-1011.
1999
-
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina with Aggrastat® [tirofiban] and Determine Cost of Therapy with Invasive or Conservative Strategy)–TIMI 18 trial.
83:317-322.
1999
-
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events..
82:19L-24L.
1998
-
Clinical potential of antithrombotic drugs in coronary syndromes.
82:11L-14L.
1998
-
Introduction.
82:1L-2L.
1998
-
A Randomized Trial of Vascular Hemostasis Techniques to Reduce Femoral Vascular Complications After Coronary Intervention 11This study was designed, supported, and internally funded by the staff of Duke University Medical Center..
81:970-976.
1998
-
Excimer Laser Coronary Angioplasty: The New Approaches to Coronary Intervention (NACI) Experience.
80:99K-105K.
1997
-
Influence of Gender on In-Hospital Clinical and Angiographic Outcomes and on One-Year Follow-Up In the New Approaches to Coronary Intervention (NACI) Registry.
80:26K-39K.
1997
-
A symposium: New frontiers in the management of unstable coronary artery disease - Introduction.
80:E1-E1.
1997
-
Fragmin in Unstable Angina Pectoris or in Non-Q-Wave Acute Myocardial Infarction (the FRIC Study).
80:30E-34E.
1997
-
New Frontiers in the Management of Unstable Coronary Artery Disease.
80:21E-24E.
1997
-
Effect of atenolol on birth weight.
79:1436-1438.
1997
-
Comparison of mortality from acute myocardial infarction between 1979 and 1992 in a geographically defined stable population.
78:1345-1349.
1996
-
Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure.
78:890-895.
1996
-
Study Design and Baseline Characteristics of the Study to Evaluate Carotid Ultrasound Changes in Patients Treated with Ramipril and Vitamin E: SECURE**This study was supported by Research Grant Ul-12363 from the Medicine Research Council of Canada, Ottawa; and by Hoechst Marion Roussel, Laval, Canada, Inc..
78:914-919.
1996
-
Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry.
77:1017-1020.
1996
-
Verapamil following uncomplicated myocardial infarction: Promising, but not proven.
77:421-422.
1996
-
Comparison of hemodynamic responses to cycling and resistance exercise in congestive heart failure secondary to ischemic cardiomyopathy.
76:977-979.
1995
-
Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction.
75:1151-1157.
1995
-
Lack of long-term ventricular arrhythmia reduction by enalapril in heart failure.
75:1244-1249.
1995
-
Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens.
75:1130-1134.
1995
-
Effect of serum lipid concentrations on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240 mg/dl and triglycerides <350 mg/dl.
75:936-938.
1995
-
Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease.
75:707-710.
1995
-
Three-month efficacy and safety of once-daily diltiazem in chronic stable angina pectoris.
75:555-558.
1995
-
ROUND-TABLE DISCUSSION.
75:B93-B97.
1995
-
Thrombosis..
75:3B-4B.
1995
-
Activation of blood coagulation by plaque rupture: Mechanisms and prevention.
75:18B-22B.
1995
-
Neurohumoral variability in left ventricular dysfunction.
75:354-359.
1995
-
Optimal intensity and monitoring warfarin.
75:39B-42B.
1995
-
introduction: Thrombosis.
75:3B-4B.
1995
-
Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (<6 weeks) Q-wave acute myocardial infarction (total occlusion post-myocardial infarction intervention study [TOMIIS]—A pilot study).
73:856-861.
1994
-
Maximizing benefits of therapies in acute myocardial infarction.
72:G145-G155.
1993
-
Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): Rationale and protocol.
72:F87-F94.
1993
-
Canadian Implantable Defibrillator Study (CIDS): Study design and organization.
72:F103-F108.
1993
-
Critical review of the approaches to the prevention of sudden death.
72:F51-F58.
1993
-
Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction.
72:154-161.
1993
-
Exercise responses after cardiac transplantation in mitochondrial myopathy.
71:1003-1006.
1993
-
Clinical characteristics of patients in Studies of Left Ventricular Dysfunction (SOLVD).
70:894-900.
1992
-
Prevalence of coronary artery disease in Asian Indians.
70:945-949.
1992
-
Studies of left ventricular dysfunction (SOLVD) registry: Rationale, design, methods and description of baseline characteristics.
70:347-353.
1992
-
Effectiveness of preload reserve as a determinant of clinical status in patients with left ventricular systolic dysfunction.
69:1591-1595.
1992
-
Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure.
69:64-70.
1992
-
Evaluation of the implantable cardioverter defibrillator in survivors of cardiac arrest: The need for randomized trials.
69:959-962.
1992
-
Reply.
69:837-837.
1992
-
Initial blood pressure response to enalapril in hospitalized patients (studies of left ventricular dysfunction [SOLVD]).
68:1465-1468.
1991
-
Are we biased in our approach to treating elderly patients with heart disease?.
68:954-956.
1991
-
Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987–1989).
68:843-847.
1991
-
Principles and practice of coronary thrombolysis and conjunctive treatment.
68:382-388.
1991
-
Diurnal variations of neurocardiac rhythms in acute myocardial infarction.
68:155-160.
1991
-
Update of effects of calcium antagonists in myocardial infarction or angina in light of the second danish verapamil infarction trial (DAVIT-II) and other recent studies.
67:1295-1297.
1991
-
Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction.
67:1084-1089.
1991
-
Usefulness of weightlifting training in improving strength and maximal power output in coronary artery disease.
67:939-945.
1991
-
Reply.
67:331-332.
1991
-
Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarction.
67:3-11.
1991
-
Comparison of direct and indirect measures of systemic arterial pressure during weightlifting in coronary artery disease.
66:1065-1069.
1990
-
CORRECTION.
66:1026-1026.
1990
-
Studies of Left Ventricular Dysfunction (SOLVD)—Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction.
66:315-322.
1990
-
Evaluating effects of treatment in subgroups of patients within a clinical trial: The case of non-Q-wave myocardial infarction and beta blockers.
66:220-222.
1990
-
Anticoagulant therapy after acute myocardial infarction.
65:C20-C23.
1990
-
Effect of tricuspid regurgitation on the reliability of the thermodilution cardiac output technique in congestive heart failure.
64:945-948.
1989
-
Influence of beta blockade on exercise capacity and heart rate response after human orthotopic and heterotopic cardiac transplantation.
64:636-641.
1989
-
Prevention of left ventricular mural thrombus.
64:41B-43B.
1989
-
Renin response to sympathetic stimulation in cyclosporin-treated heart-transplant patients.
63:1142-1144.
1989
-
The 24-hour heart rate behavior in long-term survivors of cardiac transplantation.
61:880-884.
1988
-
A controlled trial of digoxin in congestive heart failure.
61:371-375.
1988
-
Diurnal variations of QT interval after cardiac transplantation.
61:482-485.
1988
-
Evolution of the responses to exercise in left ventricular aneurysms after anterior wall acute myocardial infarction.
61:236-239.
1988
-
Effect of drug therapy on survival in chronic congestive heart failure.
62:41A-45A.
1988
-
Medical management of malignant pericardial effusion by tetracycline sclerosis.
60:1161-1166.
1987
-
Interventions that potentially limit myocardial infarct size: Overview of clinical trials.
60:11-17.
1987
-
Significance of elevated MB isoenzyme with normal creatine kinase in acute myocardial infarction.
59:245-250.
1987
-
Importance of considering ventricular function when prescribing exercise after acute myocardial infarction.
58:891-895.
1986
-
Amiodarone for refractory atrial fibrillation.
57:124-127.
1986
-
Reciprocal electrocardiographic changes in acute myocardial infarction.
56:23-26.
1985
-
Cardiovascular responses to early exercise in inferior wall ST acute myocardial infarction.
55:1277-1281.
1985
-
Effect of vasodilators on survival in chronic congestive heart failure.
55:1110-1113.
1985
-
Prevention of diminished activity of glyceryl trinitrate by use of an aerosol.
55:620-621.
1985
-
Potential for altering the natural history of congestive heart failure: Need for large clinical trials.
55:A45-A47.
1985
-
Effects on ventricular function of disopyramide, procainamide and quinidine as determined by radionuclide angiography.
53:1292-1297.
1984
-
Glucose-insulin-potassium infusion in acute myocardial infarction.
51:1566-1566.
1983
-
Predictors of dropout from cardiac exercise rehabilitation.
51:70-74.
1983
-
Relation of exercise to the recurrence rate of myocardial infarction in men.
51:65-69.
1983
-
Cardiac rupture after myocardial infarction.
42:1059-1059.
1978
-
Reply.
37:1117-1117.
1976
-
Ventricular fibrillation due to passage of a Swan-Ganz catheter.
35:589-589.
1975
-
Regional contraction patterns in the normal and ischemic left ventricle in man.
31:484-489.
1973
-
Congenital aneurysm of the membranous septum associated with bundle branch block.
14:112-117.
1964
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)